NCT04881864 (STRIDE) is a NA clinical trial of Tele-Enhance Fitness in Knee Osteoarthritis, sponsored by University of Washington.

Who is sponsoring NCT04881864?

NCT04881864 is sponsored by University of Washington.

What drugs are being tested in NCT04881864?

Interventions in NCT04881864: Tele-Enhance Fitness.

What condition does NCT04881864 study?

NCT04881864 studies Knee Osteoarthritis.

Is NCT04881864 still recruiting?

NCT04881864 is currently status unknown. Last updated 11 May 2021.

Last reviewed 2021-05-11 · How we verify

NCT04881864: STRIDE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study for Rural Innovations in the Delivery of Exercise

Status unknown NA Last updated 11 May 2021

What this trial tests

NA trial testing Tele-Enhance Fitness in Knee Osteoarthritis in 15 participants. Status unknown.

Timeline

1 January 2021

Primary endpoint
1 August 2021

1 August 2021

Quick facts

Lead sponsor	University of Washington
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	15
Start date	1 January 2021
Primary completion	1 August 2021
Estimated completion	1 August 2021
Sites	1 location across United States

Drugs / interventions tested

Tele-Enhance Fitness

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →

Sponsor

University of Washington

Who can join

65 and older, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

: Falls are the primary cause of injury and a leading cause of disability and mortality among older adults. Risk factors for falling are common among older adults with knee osteoarthritis (OA) - a highly prevalent condition. Physical exercise is consistently the most efficacious intervention for preventing falls in older adults. However, access to these programs is severely limited in rural settings. Considering that rural communities have a higher disease burden and higher proportion of older adults than non-rural areas, there is a critical need to (1) adapt evidence-based exercise programs for remote delivery to increase access for rural older adults and (2) develop pathways to implement exercise programs in rural health care systems that consistently reach and engage patients with knee OA. Accordingly, the proposed project aims to refine a protocol for remote delivery of Enhance Fitness (EF). EF is an evidence-based, group exercise program involving strength, endurance, and balance training that is recommended for falls prevention and OA management

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Remotely Delivered Exercise to Rural Older Adults With Knee Osteoarthritis: A Pilot Study.
Patel KV, Hoffman EV, Phelan EA, Gell NM. · · 2022 · cited 16× · PMID 35687577 · DOI 10.1002/acr2.11452

Verify or expand the search:

Other trials of Tele-Enhance Fitness

Trials testing the same drug.

NCT05275348 — Delivery of Enhance Fitness Trial · NA · unknown

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Other University of Washington trials

Trials by the same sponsor.

NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04881864 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Washington
Last refreshed: 11 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04881864.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing